目次

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Synthesis
1.1.3. Drug
1.1.4. Workflow
1.1.5. Application
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4

Chapter 2. Executive Summary
2.1. Market Outlook

Chapter 3. China Small Molecule CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increase in depend for one-stop-shops CDMOs.
3.3.1.2. Low cost associated with outsourcing services in China.
3.3.1.3. High geriatric population contributing to the growing diseases burden in China.
3.3.2. Market restraint analysis
3.3.2.1. Quality issues associated with outsourcing.
3.3.2.2. Limited outsourcing opted by big pharma companies
3.3.3. Covid-19 Impact & Recovery Analysis
3.3.4. Industry Analysis - Porter’s
3.3.5. PESTLE Analysis
3.3.6. Regulatory Scenario in China

Chapter 4. China Small Molecule CDMO Market: Product Segment Analysis
4.1. China Small Molecule CDMO Market : Definition & Scope
4.2. China Small Molecule CDMO Market : Product Market Share Analysis, 2022 & 2030
4.3. Active Pharmaceutical Ingredients (API)
4.3.1. Active Pharmaceutical Ingredients (API) Market, 2018 - 2030 (USD Million)
4.3.2. Innovator API Market, 2018 - 2030 (USD Million)
4.3.2.1. Innovator API Market, 2018 - 2030 (USD Million)
4.3.2.2. Traditional Active Pharmaceutical Ingredient (Traditional API)
4.3.2.2.1. Traditional Active Pharmaceutical Ingredient (Traditional API) Market, 2018 - 2030 (USD Million)
4.3.2.3. Highly Potent Active Pharmaceutical Ingredient (HP-API)
4.3.2.3.1. Highly Potent Active Pharmaceutical Ingredient (HP-API) Market, 2018 - 2030 (USD Million)
4.3.2.4. Antibody Drug Conjugate (ADC)
4.3.2.4.1. Antibody Drug Conjugate (ADC) Market, 2018 - 2030 (USD Million)
4.3.3. Generic API Market, 2018 - 2030 (USD Million)
4.3.3.1. Innovator API Market, 2018 - 2030 (USD Million)
4.3.3.2. Traditional Active Pharmaceutical Ingredient (Traditional API)
4.3.3.2.1. Traditional Active Pharmaceutical Ingredient (Traditional API) Market, 2018 - 2030 (USD Million)
4.3.3.3. Highly Potent Active Pharmaceutical Ingredient (HP-API)
4.3.3.3.1. Highly Potent Active Pharmaceutical Ingredient (HP-API) Market, 2018 - 2030 (USD Million)
4.3.3.4. Antibody Drug Conjugate (ADC)
4.3.3.4.1. Antibody Drug Conjugate (ADC) Market, 2018 - 2030 (USD Million)

Chapter 5. China Small Molecule CDMO Market: Synthesis Segment Analysis
5.1. China Small Molecule CDMO Market: Definition & Scope
5.2. China Small Molecule CDMO Market: Synthesis Market Share Analysis, 2022 & 2030
5.3. Synthetic
5.3.1. Synthetic Market, 2018 - 2030 (USD Million)
5.4. Biotech
5.4.1. Biotech Market, 2018 - 2030 (USD Million)

Chapter 6. China Small Molecule CDMO Market: Drug Segment Analysis
6.1. China Small Molecule CDMO Market: Definition & Scope
6.2. China Small Molecule CDMO Market: Drug Market Share Analysis, 2022 & 2030
6.3. Innovative
6.3.1. Innovative Market, 2018 - 2030 (USD Million)
6.4. Generic
6.4.1. Generic Market, 2018 - 2030 (USD Million)

Chapter 7. China Small Molecule CDMO Market: Workflow Segment Analysis
7.1. China Small Molecule CDMO Market: Definition & Scope
7.2. China Small Molecule CDMO Market: Workflow Market Share Analysis, 2022 & 2030
7.3. Clinical
7.3.1. Clinical Market, 2018 - 2030 (USD Million)
7.4. Commercial
7.4.1. Commercial Market, 2018 - 2030 (USD Million)

Chapter 8. China Small Molecule CDMO Market: Application Segment Analysis
8.1. China Small Molecule CDMO Market: Definition & Scope
8.2. China Small Molecule CDMO Market: Application Market Share Analysis, 2022 & 2030
8.3. Oncology
8.3.1. Oncology Market, 2018 - 2030 (USD Million)
8.4. Hormonal
8.4.1. Hormonal Market, 2018 - 2030 (USD Million)
8.5. Glaucoma
8.5.1. Glaucoma Market, 2018 - 2030 (USD Million)
8.6. Cardiovascular
8.6.1. Cardiovascular Market, 2018 - 2030 (USD Million)
8.7. Diabetes
8.7.1. Diabetes Market, 2018 - 2030 (USD Million)
8.8. Others
8.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Market Share Analysis
9.2. Participant Categorization
9.2.1. Recent Development and Impact Analysis

Chapter 10. Company Profiles
10.1. Company Overview
10.2. Financial Performance
10.3. Strategic Initiatives
10.3.1. Expansions
10.3.2. Partnerships and Collaborations
10.3.3. Acquisitions
10.3.3.1. Bellen Chemistry
10.3.3.2. Zhejiang LangHua Pharmaceutical Co., LTD.
10.3.3.3. Raffles PharmaTech Co., Ltd
10.3.3.4. Shanghai Mathcon Pharmaceutical Co., LTD
10.3.3.5. Wisdom Pharmaceutical Co., Ltd.
10.3.3.6. Gear Pharma
10.3.3.7. Hangzhou Aoya Biotechnology Co., Ltd.
10.3.3.8. Desano Inc.
10.3.3.9. Shanghai Chemspec Corporation
10.3.3.10. Zhejiang Chetou Pharmaceutical Co., Ltd

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market segmentation & scope
Fig. 8 China small molecule CDMO market outlook, 2018 - 2030
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 China small molecule CDMO market : Product outlook key takeaways
Fig. 15 China small molecule CDMO market : Product movement analysis
Fig. 16 Active Pharmaceutical Ingredients (API) market, 2018 - 2030 (USD Million)
Fig. 17 Innovator API market, 2018 - 2030 (USD Million)
Fig. 18 Traditional Active Pharmaceutical Ingredients market, 2018 - 2030 (USD Million)
Fig. 19 Highly Potent Active Pharmaceutical Ingredients (HP-API) market, 2018 - 2030
Fig. 20 Antibody Drug Conjugates (ADCs) market, 2018 - 2030 (USD Million)
Fig. 21 Generic API market, 2018 - 2030 (USD Million)
Fig. 22 Traditional Active Pharmaceutical Ingredients market, 2018 - 2030 (USD Million)
Fig. 23 Highly Potent Active Pharmaceutical Ingredients (HP-API) market, 2018 - 2030
Fig. 24 Antibody Drug Conjugates (ADCs) market, 2018 - 2030 (USD Million)
Fig. 25 Finished Drug Products market, 2018 - 2030 (USD Million)
Fig. 26 Solid market, 2018 - 2030 (USD Million)
Fig. 27 Injectable market, 2018 - 2030 (USD Million)
Fig. 28 Others market, 2018 - 2030 (USD Million)
Fig. 29 China small molecule CDMO market: Synthesis outlook key takeaways
Fig. 30 China small molecule CDMO market: Synthesis movement analysis
Fig. 31 Synthetic market, 2018 - 2030 (USD Million)
Fig. 32 Biotech market, 2018 - 2030 (USD Million)
Fig. 33 China small molecule CDMO market: Drug outlook key takeaways
Fig. 34 China small molecule CDMO market : Drug movement analysis
Fig. 35 Innovative market, 2018 - 2030 (USD Million)
Fig. 36 Generic market, 2018 - 2030 (USD Million)
Fig. 37 China small molecule CDMO market :Work Flow outlook key takeaways
Fig. 38 China small molecule CDMO market : Work Flow movement analysis
Fig. 39 Clinical market, 2018 - 2030 (USD Million)
Fig. 40 Commercial market, 2018 - 2030 (USD Million)
Fig. 41 China small molecule CDMO market :Application outlook key takeaways
Fig. 42 China small molecule CDMO market : Application movement analysis
Fig. 43 Oncology market, 2018 - 2030 (USD Million)
Fig. 44 Hormonal market, 2018 - 2030 (USD Million)
Fig. 45 Glaucoma market, 2018 - 2030 (USD Million)
Fig. 46 Cardiovascular market, 2018 - 2030 (USD Million)
Fig. 47 Diabetes market, 2018 - 2030 (USD Million)
Fig. 48 Others market, 2018 - 2030 (USD Million)